Original Articles: Allergen-Specific Immunotherapy and Biologics

Allergen-specific immunotherapy (AIT) and biologics represent two significant advancements in the treatment of allergic diseases. AIT works by desensitizing or tolerazing the immune system to specific allergens, reducing allergic reactions over time. It is commonly used to treat allergic rhinitis, allergic asthma, and stinging insect allergies. Biologics, on the other hand, are a newer class of medications that target specific molecules involved in the allergic response, providing targeted and often more effective treatment for conditions like asthma, atopic dermatitis, and chronic urticaria.

In recent years, there has been a growing interest in both AIT and biologics as effective treatment options for allergic diseases. Clinical studies have demonstrated their efficacy in improving symptoms and quality of life for patients with various allergic conditions. Furthermore, the development of new biologics and the refinement of AIT techniques continue to expand treatment options for patients worldwide.